| 摘要 |
According to the invention, a dimensionally specific physical form of polycellobiose, also called microcrystalline cellulose or microcellulose, is vehiculated in pharmaceutical forms suitable for ingestion (such as capsules, tablets, granula or powder forms, etc.) in order to obtain a regulatory effect on gastro-intestinal transit, in all conditions where cellulose and other fibres may not be well tolerated or are contraindicated. |
